Hatoshido
219A.TPharmaceutical
Filed as Heartseed Inc. (2025-01–2026-08)
Financials · Standalone
| Fiscal year ended | 2025-12 | 2024-10 | 2023-10 | 2022-10 | 2021-10 | 2020-10 |
|---|---|---|---|---|---|---|
| Revenue | ¥3.0bn | ¥874m | ¥345m | ¥499m | ¥1.6bn | — |
| Operating income | ¥272m | −¥1.0bn | −¥1.5bn | — | — | — |
| Ordinary income | ¥289m | −¥819m | −¥1.5bn | −¥1.4bn | −¥255m | −¥970m |
| Total assets | ¥7.7bn | ¥7.1bn | ¥5.7bn | ¥4.9bn | ¥6.3bn | ¥2.6bn |
| Net assets / equity | ¥7.2bn | ¥6.6bn | ¥5.3bn | ¥4.7bn | ¥6.1bn | ¥2.4bn |
| Operating cash flow | ¥1.1bn | −¥1.3bn | −¥798m | −¥1.9bn | — | — |
| EPS (basic) | ¥8.44 | ¥-49.43 | ¥-106.81 | ¥-128.99 | ¥-18,900.01 | ¥-76,652.13 |
From EDINET filings. Select any figure to open the report it came from. r = changed in a later filing (the report page shows the original). — = not reported in the filings structured so far.
Reports · 2
| Period | Form | Figures |
|---|---|---|
| 2024-11-01 → 2025-12-31 | Annual | 105 figures · EDINET |
| 2024-11-01 → 2025-04-30 | Half-year | 55 figures · EDINET |